Skip to content

eFFECTOR Therapeutics, Inc.: filings

Every eFFECTOR Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 13 filings, each linked to its SEC index.

Filing record ends 2024-05-09

The latest filing in this captured record is a 10-Q filed 2024-05-09. No later filing is in the SEC companyfacts record captured on 2026-09-22. eFFECTOR Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-09fiscal Q1 202444910000950170-24-056859
10-K2024-03-26fiscal FY 202346930000950170-24-036169
10-Q2023-11-13fiscal Q3 2023441290000950170-23-063005
10-Q2023-08-08fiscal Q2 2023441250000950170-23-039808
10-Q2023-05-09fiscal Q1 202344910000950170-23-019719
10-K2023-03-08fiscal FY 202247940000950170-23-006707
10-Q2022-11-07fiscal Q3 2022441290000950170-22-022611
10-Q2022-08-09fiscal Q2 2022441250000950170-22-016023
10-Q2022-05-10fiscal Q1 202243880000950170-22-008960
10-K2022-03-16fiscal FY 202145910000950170-22-003922
10-Q2021-11-08fiscal Q3 2021441340000950170-21-003447
10-Q2021-08-12fiscal Q2 202115280001193125-21-244053
10-Q2021-06-03fiscal Q1 202115220001193125-21-180751

Inspect the source

Entity
eFFECTOR Therapeutics, Inc. / CIK 0001828522
Captured
SEC response SHA-256
d7bb2a13321e26676197504bf872c51acefb31511f894184826b461298a753f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001828522.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))